• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对肾脏清除率增加患者的个体化抗生素给药方案。

Individualized antibiotic dosage regimens for patients with augmented renal clearance.

作者信息

Shi A-Xi, Qu Qiang, Zhuang Hai-Hui, Teng Xin-Qi, Xu Wei-Xin, Liu Yi-Ping, Xiao Yi-Wen, Qu Jian

机构信息

Department of Pharmacy, The Second Xiangya Hospital, Institute of Clinical Pharmacy, Central South University, Changsha, China.

Department of Pharmacy, The First Hospital of Lanzhou University, Lanzhou, China.

出版信息

Front Pharmacol. 2023 Jul 26;14:1137975. doi: 10.3389/fphar.2023.1137975. eCollection 2023.

DOI:10.3389/fphar.2023.1137975
PMID:37564179
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10410082/
Abstract

Augmented renal clearance (ARC) is a state of enhanced renal function commonly observed in 30%-65% of critically ill patients despite normal serum creatinine levels. Using unadjusted standard dosing regimens of renally eliminated drugs in ARC patients often leads to subtherapeutic concentrations, poor clinical outcomes, and the emergence of multidrug-resistant bacteria. We summarized pharmaceutical, pharmacokinetic, and pharmacodynamic research on the definition, underlying mechanisms, and risk factors of ARC to guide individualized dosing of antibiotics and various strategies for optimizing outcomes. We searched for articles between 2010 and 2022 in the MEDLINE database about ARC patients and antibiotics and further provided individualized antibiotic dosage regimens for patients with ARC. 25 antibiotic dosage regimens for patients with ARC and various strategies for optimization of outcomes, such as extended infusion time, continuous infusion, increased dosage, and combination regimens, were summarized according to previous research. ARC patients, especially critically ill patients, need to make individualized adjustments to antibiotics, including dose, frequency, and method of administration. Further comprehensive research is required to determine ARC staging, expand the range of recommended antibiotics, and establish individualized dosing guidelines for ARC patients.

摘要

肾脏清除率增加(ARC)是一种肾功能增强的状态,尽管血清肌酐水平正常,但在30%-65%的重症患者中普遍观察到。在ARC患者中使用未经调整的肾排泄药物标准给药方案通常会导致治疗浓度不足、临床结果不佳以及多重耐药菌的出现。我们总结了关于ARC的定义、潜在机制和危险因素的药学、药代动力学和药效学研究,以指导抗生素的个体化给药以及优化治疗结果的各种策略。我们在MEDLINE数据库中搜索了2010年至2022年间关于ARC患者和抗生素的文章,并进一步为ARC患者提供了个体化的抗生素给药方案。根据先前的研究,总结了25种ARC患者的抗生素给药方案以及各种优化治疗结果的策略,如延长输注时间、持续输注、增加剂量和联合用药方案。ARC患者,尤其是重症患者,需要对抗生素进行个体化调整,包括剂量、频率和给药方法。需要进一步进行全面研究,以确定ARC分期,扩大推荐抗生素的范围,并为ARC患者建立个体化给药指南。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ef/10410082/a6e58ed9747a/fphar-14-1137975-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ef/10410082/a6e58ed9747a/fphar-14-1137975-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ef/10410082/a6e58ed9747a/fphar-14-1137975-g001.jpg

相似文献

1
Individualized antibiotic dosage regimens for patients with augmented renal clearance.针对肾脏清除率增加患者的个体化抗生素给药方案。
Front Pharmacol. 2023 Jul 26;14:1137975. doi: 10.3389/fphar.2023.1137975. eCollection 2023.
2
Recommended Antibiotic Dosage Regimens in Critically Ill Patients with Augmented Renal Clearance: A Systematic Review.推荐剂量方案在 kritisch 病人的抗生素增强肾清除:系统回顾。
Int J Antimicrob Agents. 2022 May;59(5):106569. doi: 10.1016/j.ijantimicag.2022.106569. Epub 2022 Mar 11.
3
Implications of Augmented Renal Clearance on Drug Dosing in Critically Ill Patients: A Focus on Antibiotics.肾功能增强对重症患者药物剂量的影响:聚焦于抗生素
Pharmacotherapy. 2015 Nov;35(11):1063-75. doi: 10.1002/phar.1653.
4
Augmented Renal Clearance and How to Augment Antibiotic Dosing.增强型肾脏清除率与如何调整抗生素剂量
Antibiotics (Basel). 2020 Jul 9;9(7):393. doi: 10.3390/antibiotics9070393.
5
Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study.伴有肾脏清除率增加的危重症患者左乙拉西坦给药方案的优化:一项蒙特卡洛模拟研究
J Intensive Care. 2022 Apr 21;10(1):21. doi: 10.1186/s40560-022-00611-w.
6
Augmented Renal Clearance in Critically Ill Patients: A Systematic Review.危重症患者的增强肾脏清除率:系统评价。
Clin Pharmacokinet. 2018 Sep;57(9):1107-1121. doi: 10.1007/s40262-018-0636-7.
7
Personalized application of antimicrobial drugs in pediatric patients with augmented renal clearance: a review of literature.肾功能增强的儿科患者抗菌药物的个体化应用:文献综述
Eur J Pediatr. 2024 Jan;183(1):51-60. doi: 10.1007/s00431-023-05272-x. Epub 2023 Oct 20.
8
The Impact of Augmented Renal Clearance on Vancomycin Pharmacokinetics and Pharmacodynamics in Critically Ill Patients.强化肾清除率对重症患者万古霉素药代动力学和药效学的影响。
J Clin Med. 2024 Apr 17;13(8):2317. doi: 10.3390/jcm13082317.
9
Are Antibiotics Appropriately Dosed in Critically Ill Patients with Augmented Renal Clearance? A Narrative Review.危重症合并肾脏清除增强患者的抗生素给药是否恰当?一项叙述性综述。
Int J Clin Pract. 2022 Jan 31;2022:1867674. doi: 10.1155/2022/1867674. eCollection 2022.
10
Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill Patients.美罗培南-妥布霉素联合方案在模拟重症患者增强肾脏清除率的中空纤维感染模型中对抗耐碳青霉烯铜绿假单胞菌。
Antimicrob Agents Chemother. 2019 Dec 20;64(1). doi: 10.1128/AAC.01679-19.

引用本文的文献

1
The Definition, Prevalence, and Risk Factors of Augmented Renal Clearance in Adult Patients on Antimicrobial Therapy: A Scoping Review.抗菌治疗成年患者中强化肾清除率的定义、患病率及危险因素:一项范围综述
Infect Dis Clin Microbiol. 2025 Jun 26;7(2):123-132. doi: 10.36519/idcm.2025.504. eCollection 2025 Jun.
2
How Do Organelle-Targeting Nanotherapeutics Treat Inflammatory Diseases? A Comprehensive Review of the Literature.细胞器靶向纳米疗法如何治疗炎症性疾病?文献综述
Int J Nanomedicine. 2025 Jun 3;20:7133-7152. doi: 10.2147/IJN.S516260. eCollection 2025.
3
Development of a Population Pharmacokinetic Model of Levofloxacin in Healthy Adults and Identification of Optimal Dosing Regimens.

本文引用的文献

1
Evaluation of Vancomycin TDM Strategies: Prediction and Prevention of Kidney Injuries Based on Vancomycin TDM Results.万古霉素治疗药物监测策略评估:基于万古霉素治疗药物监测结果预测和预防肾损伤。
J Korean Med Sci. 2023 Apr 10;38(14):e101. doi: 10.3346/jkms.2023.38.e101.
2
Therapeutic Drug Monitoring of Ceftazidime-Avibactam Concentrations in Carbapenem-Resistant Infected Patients With Different Kidney Statuses.不同肾脏状态的耐碳青霉烯类感染患者中头孢他啶-阿维巴坦浓度的治疗药物监测
Front Pharmacol. 2022 Jun 22;13:780991. doi: 10.3389/fphar.2022.780991. eCollection 2022.
3
Plasma trough concentration distribution and safety of high-dose teicoplanin for patients with augmented renal clearance.
健康成年人左氧氟沙星群体药代动力学模型的建立及最佳给药方案的确定。
Pharmaceuticals (Basel). 2025 Apr 25;18(5):621. doi: 10.3390/ph18050621.
4
Innovative Antibiotic Therapies for Carbapenem-Resistant Gram-Negative Bacterial Infections: Clinical Efficacy, Safety, and Comparative Studies.用于耐碳青霉烯类革兰氏阴性菌感染的创新抗生素疗法:临床疗效、安全性及比较研究
Microorganisms. 2025 Jan 29;13(2):295. doi: 10.3390/microorganisms13020295.
5
From Cure to Crisis: Understanding the Evolution of Antibiotic-Resistant Bacteria in Human Microbiota.从治愈到危机:了解人类微生物群中抗生素耐药细菌的演变
Biomolecules. 2025 Jan 9;15(1):93. doi: 10.3390/biom15010093.
6
Chronic kidney disease and aging: dissecting the p53/p21 pathway as a therapeutic target.慢性肾脏病与衰老:剖析p53/p21信号通路作为治疗靶点
Biogerontology. 2024 Dec 26;26(1):32. doi: 10.1007/s10522-024-10173-z.
7
Dynamic distribution of systemically administered antibiotics in orthopeadically relevant target tissues and settings.系统给予的抗生素在骨科相关靶组织和环境中的动态分布。
APMIS. 2024 Dec;132(12):992-1025. doi: 10.1111/apm.13490. Epub 2024 Nov 12.
8
Suspected poor-quality medicines in Kenya: a retrospective descriptive study of medicine quality-related complaints reports in Kenya's pharmacovigilance database.肯尼亚疑似劣质药品:肯尼亚药物警戒数据库中与药品质量相关投诉报告的回顾性描述性研究。
BMC Public Health. 2024 Sep 19;24(1):2561. doi: 10.1186/s12889-024-20036-4.
9
Sepsis Stewardship: The Puzzle of Antibiotic Therapy in the Context of Individualization of Decision Making.脓毒症管理:个体化决策背景下抗生素治疗的难题
J Pers Med. 2024 Jan 18;14(1):106. doi: 10.3390/jpm14010106.
血浆谷浓度分布与高剂量替考拉宁用于伴有增强肾清除率患者的安全性。
J Clin Pharm Ther. 2022 Oct;47(10):1548-1555. doi: 10.1111/jcpt.13700. Epub 2022 May 28.
4
Semi-Automated Therapeutic Drug Monitoring as a Pillar toward Personalized Medicine for Tuberculosis Management.半自动治疗药物监测作为结核病管理个性化医疗的支柱。
Pharmaceutics. 2022 May 5;14(5):990. doi: 10.3390/pharmaceutics14050990.
5
Cefepime population pharmacokinetics and dosing regimen optimization in critically ill children with different renal function.头孢吡肟在不同肾功能危重症儿童中的群体药动学和给药方案优化。
Clin Microbiol Infect. 2022 Oct;28(10):1389.e1-1389.e7. doi: 10.1016/j.cmi.2022.05.007. Epub 2022 May 20.
6
Multicenter Population Pharmacokinetic Study of Unbound Ceftriaxone in Critically Ill Patients.多中心危重症患者游离头孢曲松群体药代动力学研究。
Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0218921. doi: 10.1128/aac.02189-21. Epub 2022 May 16.
7
Therapeutic drug monitoring of cefepime in a non-critically ill population: retrospective assessment and potential role for model-based dosing.非危重症人群中头孢吡肟的治疗药物监测:回顾性评估及基于模型给药的潜在作用
JAC Antimicrob Resist. 2022 Apr 21;4(2):dlac043. doi: 10.1093/jacamr/dlac043. eCollection 2022 Apr.
8
Augmented Renal Clearance of Vancomycin in Suspected Sepsis: Single-Center, Retrospective Pediatric Cohort.疑似脓毒症患者中万古霉素的增强肾清除率:单中心回顾性儿科队列研究。
Pediatr Crit Care Med. 2022 Jun 1;23(6):444-452. doi: 10.1097/PCC.0000000000002918. Epub 2022 Feb 22.
9
Investigation of pharmacokinetic and clinical outcomes of various meropenem regimens in patients with ventilator-associated pneumonia and augmented renal clearance.不同美罗培南给药方案在呼吸机相关性肺炎合并肾脏清除率增加患者中的药代动力学及临床结局研究。
Eur J Clin Pharmacol. 2022 May;78(5):823-829. doi: 10.1007/s00228-022-03291-5. Epub 2022 Feb 16.
10
Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives.利用治疗药物监测优化治疗:当前策略与未来展望
Gastroenterology. 2022 Apr;162(5):1512-1524. doi: 10.1053/j.gastro.2022.02.014. Epub 2022 Feb 12.